Committees’ consolidated opinions on application for authorisation available
The consolidated opinions of the Committees for Risk Assessment (RAC) and Socio-economic Analysis (SEAC) are available for application for authorisation for 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated by Kedrion S.p.A; Abbott Diagnostics GmbH; and Eli Lilly Kinsale Limited.